Kidney and recipient weight incompatibility reduces long-term graft survival.

PubWeight™: 2.08‹?› | Rank: Top 2%

🔗 View Article (PMC 2900958)

Published in J Am Soc Nephrol on May 20, 2010

Authors

Magali Giral1, Yohann Foucher, Georges Karam, Yann Labrune, Michelle Kessler, Bruno Hurault de Ligny, Mathias Büchler, François Bayle, Carole Meyer, Nathalie Trehet, Pascal Daguin, Karine Renaudin, Anne Moreau, Jean Paul Soulillou

Author Affiliations

1: Institut de Transplantation et de Recherche en Transplantation, ITERT, CHU Nantes, Réseau Thématique de Recherche et de Soins Centaure, Nantes and INSERM U643 (Immunointervention dans les Allo et Xénotransplantation), Centre d'Investigation Clinique biothérapie, 30 bd Jean Monnet, 44093, Nantes, France.

Articles citing this

Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33

The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective. J Am Soc Nephrol (2014) 1.01

Genetic mosaic analysis reveals a major role for frizzled 4 and frizzled 8 in controlling ureteric growth in the developing kidney. Development (2011) 0.96

Low nephron number and its clinical consequences. Rambam Maimonides Med J (2011) 0.85

The Impact of Kidney Development on the Life Course: A Consensus Document for Action. Nephron (2017) 0.82

Validity of surrogate measures for functional nephron mass. Transplantation (2011) 0.81

Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation. Clin J Am Soc Nephrol (2017) 0.78

Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. World J Urol (2013) 0.78

Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies. Medicine (Baltimore) (2015) 0.77

Clinical implications for graft function of a new equation model for the ratio of living donor kidney volume to recipient body surface area. Korean J Urol (2013) 0.77

Donor and recipient size mismatch in adolescents undergoing living-donor renal transplantation affect long-term graft survival. Transplantation (2013) 0.77

Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. J Clin Invest (2015) 0.76

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years - The PreKit-QoL study protocol. BMC Nephrol (2016) 0.75

Donor Quality in the Eye of the Beholder: Interactions between Nonimmunologic Recipient and Donor Factors as Determinants of Graft Survival. Clin J Am Soc Nephrol (2017) 0.75

Glomerular Function and Structure in Living Donors: Lessons from Single Nephron Studies. Curr Transplant Rep (2016) 0.75

Transplantation: A low donor kidney weight to recipient weight ratio is associated with decreased long-term graft survival. Nat Rev Nephrol (2010) 0.75

Transplantation: strength in numbers-predicting long-term transplant outcomes. Nat Rev Nephrol (2011) 0.75

Size matters in renal allograft survival. J Am Soc Nephrol (2010) 0.75

Does graft mass impact on pediatric kidney transplant outcomes? Pediatr Nephrol (2014) 0.75

A study to evaluate the effect of ratio of donor kidney weight to recipient body weight on renal graft function. Urol Ann (2014) 0.75

A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size. Clin J Am Soc Nephrol (2017) 0.75

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants. Transplant Direct (2017) 0.75

Articles cited by this

Long-term consequences of kidney donation. N Engl J Med (2009) 10.17

Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant (2004) 4.06

Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec (1992) 3.30

Nephron adaptation to renal injury or ablation. Am J Physiol (1985) 2.65

Long-term follow-up after partial removal of a solitary kidney. N Engl J Med (1991) 1.99

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int (2003) 1.91

Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant (2005) 1.82

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int (2001) 1.77

Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant (2002) 1.70

Long-term effects of reduced renal mass in humans. Kidney Int (1995) 1.39

A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int (2000) 1.35

Generalized maximally selected statistics. Biometrics (2008) 1.28

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol (2001) 1.24

Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation (1999) 1.22

Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int (1984) 1.22

Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int (1998) 1.15

Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation (2001) 1.10

Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant (2004) 1.09

Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation (1997) 1.07

Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol (2002) 1.07

Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis (1993) 1.05

Impact of graft mass on the clinical outcome of kidney transplants. J Am Soc Nephrol (2004) 1.03

Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int (1983) 1.00

Ratio of donor kidney weight to recipient bodyweight as an index of graft function. Lancet (2001) 1.00

Antigen-independent determinants of cadaveric kidney transplant failure. JAMA (1996) 0.99

Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. Clin Transpl (2003) 0.94

Influence of proteinuria on long-term transplant survival in kidney transplant recipients. Nephron (1997) 0.93

Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest (1994) 0.93

Long-term follow-up of humans with single kidneys: the need for longitudinal studies to assess true changes in renal function. Curr Opin Nephrol Hypertens (1993) 0.91

Effects of sex on renal structure. Nephron (2002) 0.91

Effect of donor/recipient body weight mismatch on patient and graft outcome in living-donor kidney transplantation. Am J Nephrol (2003) 0.91

Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation (1997) 0.90

Importance of renal mass on graft function outcome after 12 months of living donor kidney transplantation. Nephrol Dial Transplant (2007) 0.89

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int (1999) 0.85

Importance of donor/recipient body weight ratio as a cause of kidney graft loss in the short to medium term. Nephron (1996) 0.83

The effect of kidney size on cadaveric renal allograft outcome. Transplantation (1996) 0.83

Impact of donor/recipient size matching on outcomes in renal transplantation. Transplantation (1996) 0.82

Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives. Kidney Int (1990) 0.81

Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats. Kidney Int Suppl (1995) 0.81

Glomerular size in early protocol biopsies is associated with graft outcome. Am J Transplant (2005) 0.80

Recipient body surface area as a predictor of posttransplant renal allograft evolution. Transplantation (1998) 0.80

Articles by these authors

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica (2007) 3.23

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood (2008) 3.10

Assisted peritoneal dialysis. Experience in a French renal department. Perit Dial Int (2006) 2.53

Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet (2012) 2.34

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 2.27

Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s. Eur Urol (2006) 2.10

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood (2005) 1.99

Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol (2008) 1.95

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood (2007) 1.91

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87

Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood (2005) 1.86

Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am J Kidney Dis (2009) 1.77

A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol (2003) 1.77

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation (2006) 1.75

Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transpl Int (2011) 1.73

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial. Transplantation (2016) 1.68

Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int (2007) 1.65

Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev Biol (2006) 1.61

Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58

Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol (2003) 1.57

Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. Kidney Int (2010) 1.57

Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer. Clin Genitourin Cancer (2012) 1.56

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? BJU Int (2012) 1.56

Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients. Nephrol Dial Transplant (2003) 1.51

Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial. Transplantation (2007) 1.50

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol (2013) 1.50

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation (2005) 1.41

18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol (2012) 1.39

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol (2003) 1.38

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol (2005) 1.36

Initiation of gastrulation in the mouse embryo is preceded by an apparent shift in the orientation of the anterior-posterior axis. Curr Biol (2004) 1.35

Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits. Diabetes (2009) 1.29

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl (2005) 1.28

Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl (2003) 1.24

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant (2002) 1.23

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol (2006) 1.20

Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood (2007) 1.20

Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation. Sci Transl Med (2010) 1.17

Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol (2010) 1.11

Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol (2008) 1.11

Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol (2004) 1.10

Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol (2009) 1.09

Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy. J Urol (2002) 1.09

Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months. Kidney Int (2003) 1.07

Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging (2009) 1.07

[Complications of Bricker ileal conduit urinary diversion: analysis of a series of 246 patients]. Prog Urol (2005) 1.06

Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol (2009) 1.05

Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant (2002) 1.04

Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation (2008) 1.04

Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol (2002) 1.04

A clinical scoring system highly predictive of long-term kidney graft survival. Kidney Int (2010) 1.03

Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem (2008) 1.03

Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol (2008) 1.03

Impact of graft mass on the clinical outcome of kidney transplants. J Am Soc Nephrol (2004) 1.03

Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma. J Clin Oncol (2012) 1.02

Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int (2002) 1.01

Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy. Clin Transplant (2003) 1.01

Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience. Nephrol Dial Transplant (2008) 1.01

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group. Eur J Nucl Med Mol Imaging (2010) 0.99

Common variants in FTO, MC4R, TMEM18, PRL, AIF1, and PCSK1 show evidence of association with adult obesity in the Greek population. Obesity (Silver Spring) (2011) 0.99

18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging (2010) 0.99

Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French Consortium GRAGIL. Diabetes Care (2004) 0.97

Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One (2013) 0.97

ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents. Clin Cancer Res (2011) 0.96

Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci (2002) 0.95

Rapid failure of pig islet transplantation in non human primates. Xenotransplantation (2002) 0.95

Recovery from a variegate porphyria by a liver transplantation. Liver Transpl (2004) 0.94

Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant (2005) 0.93

Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol (2007) 0.92

Clonal and molecular analysis of the prospective anterior neural boundary in the mouse embryo. Development (2012) 0.92

Systemic vasculitis with lymphocytic temporal arteritis and Toxocara canis infection. Arch Intern Med (2002) 0.92

[News in peritoneal dialysis]. Presse Med (2007) 0.92

Gene expression profiling in sinonasal adenocarcinoma. BMC Med Genomics (2009) 0.90

Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol (2002) 0.90

Nodal cis-regulatory elements reveal epiblast and primitive endoderm heterogeneity in the peri-implantation mouse embryo. Dev Biol (2010) 0.90

Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxide. Kidney Int (2003) 0.90